Tennessee Cannabiz

  Trump's Cannabis From Schedule I to Schedule III Move Dear President Trump, I want to extend a sincere and enthusiastic thank you for your leadership in considering and moving forward with the rescheduling of marijuana from a Schedule I to a Schedule III controlled substance — a step that has already begun to reshape the national conversation around cannabis, research, and medical science. Your public remarks acknowledging that many people want this reclassification because it “leads to tremendous amounts of research that can’t be done unless you reclassify” reflect a willingness to look beyond old stigmas and recognize the potential for science and medicine to understand cannabis more fully. This shift — which would acknowledge cannabis as a substance with accepted medical use and a lower potential for abuse relative to Schedule I drugs — marks one of the most significant federal policy considerations in decades. By opening the door to research, innovation, an...

Hemp Industry Faces Regulatory Storm After New Federal Funding Bill — But the Fight Isn’t Over The hemp industry is in a firefight right now — regrouping and preparing for a major lobbying push after a federal government funding package dropped a bombshell provision that could outlaw nearly all hemp-derived products containing THC . What Just Happened? The recently passed funding bill tightened the legal definition of hemp to ban any hemp-derived product with THC, even the types legalized by the landmark 2018 Farm Bill . The new rules cap THC at a microscopic 0.4 milligrams per container — a limit so tight that most hemp products, even the non-intoxicating ones, reportedly exceed it. This crackdown also targets cannabinoids like delta-8 THC , which are synthesized or manufactured outside the plant. These now fall under the ban, too. The Food and Drug Administration (FDA) has been given 90 days to release a list defining natural vs. synthetic cannabinoids and what exactly cou...